Trial
NCT01345136
Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
Novartis Pharmaceuticals
Condition
Neurofibromatosis Type 2
Intervention
RAD001, everolimus
Why stopped
slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-13